BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 33682641)

  • 1. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Xu M; Li XL; Zhu FC; Liang ZL
    J Med Virol; 2015 Dec; 87(12):2009-17. PubMed ID: 26010334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
    Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013-2022.
    Yang Q; Liu F; Chang L; Lai S; Teng J; Duan J; Jian H; Liu T; Che G
    Virol J; 2023 Sep; 20(1):202. PubMed ID: 37661256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine.
    Li J; Pan H; Wang X; Zhu Q; Ge Y; Cai J; Li Y; Xia A; Hu J; Zeng M
    Emerg Microbes Infect; 2018 Mar; 7(1):37. PubMed ID: 29559626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
    Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
    Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
    Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
    BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
    Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
    Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China.
    Guo W; Xu D; Cong S; Du Z; Li L; Zhang M; Feng C; Bao G; Sun H; Yang Z; Ma S
    BMC Infect Dis; 2022 Aug; 22(1):671. PubMed ID: 35927711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of enteroviruses in healthy populations and excretion of pathogens in patients with hand, foot, and mouth disease in a highly endemic area of southwest China.
    Wu Q; Fu X; Jiang L; Yang R; Cun J; Zhou X; Zhou Y; Xiang Y; Gu W; Fan J; Li H; Xu W
    PLoS One; 2017; 12(7):e0181234. PubMed ID: 28704524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.